Never miss an important update

Click    to get notified about important updates only.   

99 push-notification-bg

99 Alternatives

We are sorry that you have opted out.

However, if you accidentally selected "Block" or you want to receive notifications in the future, then follow any of the following instructions.

Option 1

99 chrome-b-n

Option 2

1. visit to Chrome > Settings > Content Settings

2. click here Content Settings > Notifications > Manage Exceptions

OR

Copy & Paste in Addrsss Bar > "chrome://settings/content/notifications?search=notif"

3. Select Allow for https://www.99alternatives.com/

4. Refresh the page.

99 Alternatives

Opportunities are Infinite

Please wait
99 Alternative logo
Business
All Categories

Investors Space-Spreading Awareness

Join a community that's informative, communicative & Interactive

99 Alternatives-Taking Initiative

99 top-hearder-guide-book
Register Today to Download Your Free
Alternative Asset Guide for 2019
Worth £49.99 and Free Life Time
Subscription to 99 Alternatives Web Portal
Worth £100's Limited Availability…
register for e Asset Guide
Latest News
Coronavirus outbreak may disrupt Apple's iPhone production ramp up plans - Nikkei
Six euro zone banks fall short of ECB capital demands
Just Eat sees 2019 earnings in line, partners McDonald's in UK
Virgin Money loan book grows, but still warns of Brexit uncertainty
Swedbank reports smaller-than-expected fall in fourth quarter profit
Stocks crumble as China virus toll mounts, safe havens in favour
Scam Alerts
What Is The Computer Misuse Act?
Call Centre Scams Conning People
The easy way to stop your online accounts getting hacked
Fraudster sentenced after funding luxury holidays through £50k smishing scam
Banking industry stops £4.5 million of fraud a day in first half of 2019
Barclays issues warning to university students, as number of under-21s recruited as money mules..
Euston Road Bangor-ad-399 Ads

Novartis names Bulto as new head of U.S. drugs business

FILE PHOTO: Swiss drugmaker Novartis' logo is seen in Stein
Share:
ZURICH (Reuters) - Swiss drugmaker Novartis has named company veteran Victor Bulto as head of its U.S. pharmaceuticals business, effective on Sept. 1.He replaces Fabrice Chouraqui, who will step down at the end of August, Novartis said in a statement.It gave no reason for the switch, which comes as the drugmaker faces U.S. scrutiny over its handling of a case of manipulated data linked to its $2..
Date Published: Aug 14, 2019
To view the full article, Register Now.
Register Today And Get Your Free Lifetime Elite Subscription Worth £100’s
Are You Already a Member? Login
Interact-With-Prospective-Clients_728x9099 Ads

Related Articles

Interact-With-Prospective-Clients_300x25099 Ads

Video

Copyright © 2020 99alternatives Ltd.   All rights reserved.

Designed and Managed by Mont Digital